P

Inventor

CHEN ZHAOGUO

CN9 patents
⚠️ This page may combine multiple inventors who share the name “CHEN ZHAOGUO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MEDSHINE DISCOVERY INC

5 patents
US11117899B2Sep 14, 2021

[1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor

MEDSHINE DISCOVERY INC3 citations71
US9856264B2Jan 2, 2018

Isoquinolinesulfonyl derivative as RHO kinase inhibitor

MEDSHINE DISCOVERY INC3 citations71
US11377444B2Jul 5, 2022

Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors

MEDSHINE DISCOVERY INC1 citations61
US11649239B2May 16, 2023

Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1)

MEDSHINE DISCOVERY INC0 citations59
US12030897B2Jul 9, 2024

Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereof

MEDSHINE DISCOVERY INC0 citations48

CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD

1 patent
US11433053B2Sep 6, 2022

LSD1 inhibitor and preparation method and application thereof

CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD3 citations71

CSTONE PHARMACEUTICAL SUZHOU CO LTD

1 patent
US12583869B2Mar 24, 2026

Salt form and crystal form of A2A receptor antagonist and preparation method therefor

CSTONE PHARMACEUTICAL SUZHOU CO LTD0 citations55

CHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LTD

1 patent
US11155559B2Oct 26, 2021

Sulfonyl-substituted isoquinolines as inhibitors of RHO kinase and hERG potassium channel activity

CHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LTD0 citations55

GUIZHOU INOCHINI TECH CO LTD

1 patent
US11046720B2Jun 29, 2021

Dimethylphosphine oxide compound

GUIZHOU INOCHINI TECH CO LTD0 citations43